highly significantp < 0.0001
Expression profiling revealed that SLC7A5 was significantly differentially expressed across cell types, particularly between epithelial cells and fibroblasts, mast cells, plasma cells, and T cells, with highly significant differences (p < 0.0001), suggesting cell type–specific functional roles ( Figure 6G ). 3.7 Mechanistic insights into the role of SLC7A5 in BRCA Gene set enrichment analysis (GSEA) revealed that low-SLC7A5–expressing samples exhibited downregulation of pathways related to immune responses, cell adhesion, and proliferation, including allograft rejection, cell adhesion molecules, cell cycle, and cytokine–cytokine receptor interaction ( Figures 7A, C ).